Low BOK Expression Promotes Epithelial–Mesenchymal Transition and Migration via the Wnt Signaling Pathway in Breast Cancer Cells
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26157252 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ling Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Fertility Preservation and Maintenance of Ministry of Education, School of Basic Medical Sciences, Ningxia Medical University, Yinc…. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Wnt Signaling Pathway, Cell Movement, Breast Neoplasms. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the Natural Science Foundation of Ningxia.
Abstract (Originalsprache)
The B-cell lymphoma 2 (Bcl-2)-related ovarian killer (BOK), a member of the Bcl-2 protein family, shares a similar domain structure and amino acid sequence homology with the pro-apoptotic family members BAX and BAK. Although BOK is involved in the development of various types of cancer, its mechanism of action in breast cancer remains unclear. This study found that BOK was involved in the process of MG132, inhibiting the migration and epithelial–mesenchymal transition (EMT) of breast cancer cells induced by transforming growth factor-β. Furthermore, interfering BOK reversed the inhibition of breast cancer cell migration and the EMT process by MG132. Additional studies revealed that BOK silencing promoted the expression of EMT-related markers in breast cancer cells, while BOK overexpression inhibited EMT and migration. Using RNA-seq sequencing and Western blotting, we confirmed that the Wnt signaling pathway is involved in BOK regulating the EMT process in breast cancer cells. Therefore, we conclude that low BOK expression promotes breast cancer EMT and migration by activating the Wnt signaling pathway. This study enhances our understanding of breast cancer pathogenesis and suggests that BOK may serve as a potential prognostic marker and therapeutic target for breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Fertility Preservation and Maintenance of Ministry of Education, School of Basic Medical Sciences, Ningxia Medical University, Yinchuan 750004, China.
ORCID-Profile: Xufeng Fu
Förderung
- National Natural Science Foundation of China
- the Natural Science Foundation of Ningxia
Zitieren
APA
Liu, L., He, T., Zhang, Z., Dai, W., Ding, L., Yang, H., Xu, B., Shang, Y., Deng, Y., Fu, X., & Du, X. (2025). Low BOK Expression Promotes Epithelial–Mesenchymal Transition and Migration via the Wnt Signaling Pathway in Breast Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157252
Vancouver
Liu L, He T, Zhang Z, Dai W, Ding L, Yang H, et al. Low BOK Expression Promotes Epithelial–Mesenchymal Transition and Migration via the Wnt Signaling Pathway in Breast Cancer Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157252
BibTeX
@article{Liu2025,
author = {Liu, Ling and He, Tiantian and Zhang, Zhen and Dai, Wenjie and Ding, Liyang and Yang, Hong and Xu, Bo and Shang, Yitong and Deng, Yu and Fu, Xufeng and Du, Xing},
title = {Low BOK Expression Promotes Epithelial–Mesenchymal Transition and Migration via the Wnt Signaling Pathway in Breast Cancer Cells},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26157252}
}
EUVIMED